Webinar: Improving testing for HIV and related co-infections in general practice

Topic outline

• Webinar: Improving testing for HIV and related co-infections in general practice

  Webinar: Improving testing for HIV and related co-infections in general practice

  21 March 2023, 15:00-16:00 CET

  Welcome to the 'Improving testing for HIV and related co-infections in general practice' webinar space on EVA.

  The overall aim of this online webinar organised by ECDC, European Clinical AIDS Society (EACS) and the Centre of Excellence for Health, Immunity and Infections (CHIP) is to increase general practitioner and nurse knowledge and awareness of integrated testing, including indicator guided testing, why this is important, and what can be done to increase testing for HIV and related co-infections in practice.

  Below you will see more information about this webinar and support materials.

  If you have any questions regarding the webinar, please contact the Coordination team at countrysupport.rigshospitalet@regionh.dk. If you have any technical issues, please contact courses@ecdc.europa.eu.

  • FileRecording of presentations
  • Objectives

    At the end of the webinar, participants should have:

    • Increased understanding of common HIV indicator conditions and co-infections such a viral hepatitis, STIs and tuberculosis;
    • Increased knowledge existing integrated testing guidance, including indicator guided testing, and why this is important;
    • Understand how to implement indicator guided testing in practice.

  • Target audience

    This webinar is aimed toward (i) nurses and (ii) physicians working in general practices in EU/EEA countries.

  • Programme

    The webinar will be hosted online using Zoom with a duration of 60 minutes. The format will include expert plenary presentations and open discussion/Q&A. 

    21 March 2023, 15:00 – 16:00 CET
    Time	Purpose and activity	Facilitator(s)
    15:00	Common HIV Indicator Conditions and Co-infections	Anastasia Pharris, ECDC
    15:10	Effectiveness of HIV Indicator Condition Testing	Ann Sullivan, EACS
    15:20	Country examples: ·         Tuberculosis Clinic, Romania ·         Primary Care setting, UK	Victor-lonel Grecu, Victor Babes Clinical Hospital
    		David Mummery, Churchill Medical Centre
    15:25	Q&A	Anastasia Pharris, ECDC
    15:35	Implementing HIV Indicator Condition Testing in Primary Care	Ann Sullivan, EACS
    15:50	Take-home messages and evaluation	ECDC, CHIP

    
    

  • Background material

    We have selected relevant documents related to the webinar content as background material. These materials provide support to the planned webinar presentations and discussions:

    ECDC testing guidance

    • Public health guidance on HIV, hepatitis B and C testing in the EU/EEA 
    • Technical Report: Technologies, strategies and approaches for testing populations at risk of sexually transmitted infections in the EU/EEA
    • Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA
    • Models of good practice for community-based testing, linkage to care and adherence to treatment for hepatitis B and C, HIV, and tuberculosis and for health promotion interventions to prevent infections among people who inject drugs

    
    

    EuroTEST project resources

    • Indicator Condition Guided HIV Testing: HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Setting
    • HIV indicator diseases across Europe study (HIDES): HIV testing audit tool
    • OptTEST: Tools for Implementing Indicator Condition (IC) Guided Testing 
    • INTEGRATE: Tools for Integrated Testing in Health Care Settings

    
    

    Clinical guidelines from different disease specialties

    • European AIDS Clinical Society (EACS): Guidelines for the management of people living with HIV in Europe
    • European Academy of Dermatology and Venereology (EADV): Raising awareness of HIV in dermatology and venereology
    • International Union against Sexually Transmitted Infections (IUSTI): Guidelines/Resources
    • European Association for the Study of the Liver (EASL): Clinical Practice Guidelines

    
    

    WHO testing guidance

    • Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
    • Guidelines on hepatitis B and C testing
    • Guidelines for the management of symptomatic sexually transmitted infections
    • Consolidated guidelines on tuberculosis: module 3: diagnosis: tests for TB infection
    • Framework for collaborative action on tuberculosis and comorbidities
    • Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

    
    

    ECDC and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Prevention and control of infectious diseases among people who inject drugs